Aseptic abscess syndrome: a case report of a patient achieving remission with both infliximab originator and biosimilar administered at varied intervals
Aseptic abscesses syndrome is a rare but increasingly recognized disease that falls within the spectrum of autoinflammatory disorders. Here, we describe the case of a patient who presented with abdominal pain and fever, along with multiple abdominal and extra-abdominal abscesses, in the absence of u...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-12-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1454813/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1846142750766923776 |
|---|---|
| author | Federica Maria Ucci Rossana Scrivo Cristiano Alessandri Fabrizio Conti Roberta Priori Roberta Priori |
| author_facet | Federica Maria Ucci Rossana Scrivo Cristiano Alessandri Fabrizio Conti Roberta Priori Roberta Priori |
| author_sort | Federica Maria Ucci |
| collection | DOAJ |
| description | Aseptic abscesses syndrome is a rare but increasingly recognized disease that falls within the spectrum of autoinflammatory disorders. Here, we describe the case of a patient who presented with abdominal pain and fever, along with multiple abdominal and extra-abdominal abscesses, in the absence of underlying hematologic, autoimmune, infectious, or neoplastic conditions. Initially, the patient responded to glucocorticoids, but experienced several flares upon discontinuation, leading to the initiation of treatment with a TNFα inhibitor. After 5 years, an attempt to discontinue treatment resulted in a new flare of the disease. Remission was eventually achieved with a biosimilar TNFα inhibitor, albeit requiring shortened infusion intervals. |
| format | Article |
| id | doaj-art-a3e4e51d1b7a4a1d8dc391619ed96a1f |
| institution | Kabale University |
| issn | 1664-3224 |
| language | English |
| publishDate | 2024-12-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Immunology |
| spelling | doaj-art-a3e4e51d1b7a4a1d8dc391619ed96a1f2024-12-03T05:10:03ZengFrontiers Media S.A.Frontiers in Immunology1664-32242024-12-011510.3389/fimmu.2024.14548131454813Aseptic abscess syndrome: a case report of a patient achieving remission with both infliximab originator and biosimilar administered at varied intervalsFederica Maria Ucci0Rossana Scrivo1Cristiano Alessandri2Fabrizio Conti3Roberta Priori4Roberta Priori5Department of Clinical Internal, Anesthesiologic and Cardiovascular Sciences, Rheumatology Unit, Sapienza University of Rome, Rome, ItalyDepartment of Clinical Internal, Anesthesiologic and Cardiovascular Sciences, Rheumatology Unit, Sapienza University of Rome, Rome, ItalyDepartment of Clinical Internal, Anesthesiologic and Cardiovascular Sciences, Rheumatology Unit, Sapienza University of Rome, Rome, ItalyDepartment of Clinical Internal, Anesthesiologic and Cardiovascular Sciences, Rheumatology Unit, Sapienza University of Rome, Rome, ItalyDepartment of Clinical Internal, Anesthesiologic and Cardiovascular Sciences, Rheumatology Unit, Sapienza University of Rome, Rome, ItalySaint Camillus International University of Health Science, UniCamillus, Rome, ItalyAseptic abscesses syndrome is a rare but increasingly recognized disease that falls within the spectrum of autoinflammatory disorders. Here, we describe the case of a patient who presented with abdominal pain and fever, along with multiple abdominal and extra-abdominal abscesses, in the absence of underlying hematologic, autoimmune, infectious, or neoplastic conditions. Initially, the patient responded to glucocorticoids, but experienced several flares upon discontinuation, leading to the initiation of treatment with a TNFα inhibitor. After 5 years, an attempt to discontinue treatment resulted in a new flare of the disease. Remission was eventually achieved with a biosimilar TNFα inhibitor, albeit requiring shortened infusion intervals.https://www.frontiersin.org/articles/10.3389/fimmu.2024.1454813/fullaseptic abscess syndromeautoinflammatory disorderTNFα-inhibitorbiosimilarnon-medical switch |
| spellingShingle | Federica Maria Ucci Rossana Scrivo Cristiano Alessandri Fabrizio Conti Roberta Priori Roberta Priori Aseptic abscess syndrome: a case report of a patient achieving remission with both infliximab originator and biosimilar administered at varied intervals Frontiers in Immunology aseptic abscess syndrome autoinflammatory disorder TNFα-inhibitor biosimilar non-medical switch |
| title | Aseptic abscess syndrome: a case report of a patient achieving remission with both infliximab originator and biosimilar administered at varied intervals |
| title_full | Aseptic abscess syndrome: a case report of a patient achieving remission with both infliximab originator and biosimilar administered at varied intervals |
| title_fullStr | Aseptic abscess syndrome: a case report of a patient achieving remission with both infliximab originator and biosimilar administered at varied intervals |
| title_full_unstemmed | Aseptic abscess syndrome: a case report of a patient achieving remission with both infliximab originator and biosimilar administered at varied intervals |
| title_short | Aseptic abscess syndrome: a case report of a patient achieving remission with both infliximab originator and biosimilar administered at varied intervals |
| title_sort | aseptic abscess syndrome a case report of a patient achieving remission with both infliximab originator and biosimilar administered at varied intervals |
| topic | aseptic abscess syndrome autoinflammatory disorder TNFα-inhibitor biosimilar non-medical switch |
| url | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1454813/full |
| work_keys_str_mv | AT federicamariaucci asepticabscesssyndromeacasereportofapatientachievingremissionwithbothinfliximaboriginatorandbiosimilaradministeredatvariedintervals AT rossanascrivo asepticabscesssyndromeacasereportofapatientachievingremissionwithbothinfliximaboriginatorandbiosimilaradministeredatvariedintervals AT cristianoalessandri asepticabscesssyndromeacasereportofapatientachievingremissionwithbothinfliximaboriginatorandbiosimilaradministeredatvariedintervals AT fabrizioconti asepticabscesssyndromeacasereportofapatientachievingremissionwithbothinfliximaboriginatorandbiosimilaradministeredatvariedintervals AT robertapriori asepticabscesssyndromeacasereportofapatientachievingremissionwithbothinfliximaboriginatorandbiosimilaradministeredatvariedintervals AT robertapriori asepticabscesssyndromeacasereportofapatientachievingremissionwithbothinfliximaboriginatorandbiosimilaradministeredatvariedintervals |